LNP formulation

ACON Pharma is a privately held specialty pharmaceutical company based in Princeton, New Jersey, USA, focused on siRNA, mRNA, circular RNA, LNP technologies, drug delivery systems, and complex 505(b)(2) NDA and ANDA drug development. It develops RNA therapeutics and small molecule pipelines using proprietary drug delivery platforms and provides contract development and manufacturing services.

contract development and manufacturingdrug delivery system developmentliposome formulationmg to kg scale synthesismicrosphere formulationnanoparticle formulationnucleic acid chemistryoral dissolving filmsiRNA/mRNA designtransdermal systems

Artis BioSolutions is a synthetic DNA and advanced therapy platform company that combines proprietary enzymatic, cell-free synthetic DNA production (oDNA) with advanced therapy development and GMP manufacturing. It operates in the United States and European Union, with GMP and RUO manufacturing in Watertown, MA and Bilbao, Spain, supporting mRNA, gene editing, viral vectors, cell therapies, vaccines, and emerging biologics.

AAV viral vector manufacturinganalytical developmentCMC strategyenzymatic cell-free synthetic DNA manufacturingfill/finishGMP manufacturinglentiviral vector manufacturingmRNA manufacturingprocess developmentquality control

Curia is a global contract research, development and manufacturing organization (CDMO) with over 30 years of experience guiding clients through drug discovery, development, and manufacturing. It offers services across Small Molecule, Generic APIs, Sterile Drug Product, and Biologics, operating an integrated network of 20+ facilities and 3,000+ professionals across North America, Europe, and India.

analytical testingantibody discovery and engineeringchemical process R&Ddownstream process developmentdrug discoveryfermentationflow chemistryGMP manufacturinghigh potency API (HPAPI) manufacturingmammalian cell line developmentmRNA process developmentrecombinant antibody productionrecombinant protein productionsterile API manufacturingupstream process development